These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11576898)

  • 1. A new role for progesterone: an agonist for mineralocorticoid receptor activation and pregnancy-related hypertension.
    Hayslett JP
    Am J Kidney Dis; 2001 Oct; 38(4):893-5. PubMed ID: 11576898
    [No Abstract]   [Full Text] [Related]  

  • 2. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.
    Geller DS; Farhi A; Pinkerton N; Fradley M; Moritz M; Spitzer A; Meinke G; Tsai FT; Sigler PB; Lifton RP
    Science; 2000 Jul; 289(5476):119-23. PubMed ID: 10884226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy.
    Weinberger MH; Kramer NJ; Petersen LP; Cleary RE; Young PC
    Perspect Nephrol Hypertens; 1976; 5():263-9. PubMed ID: 1005040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the S810L point mutation of the mineralocorticoid receptor in patients with pregnancy-induced hypertension.
    Schmider-Ross A; Wirsing M; Büscher U; Neitzel H; Krause M; Henrich W; Reles A; Dudenhausen JW
    Hypertens Pregnancy; 2004; 23(1):113-9. PubMed ID: 15117605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension in women: the role of progesterone and aldosterone.
    Boschitsch E; Mayerhofer S; Magometschnigg D
    Climacteric; 2010 Aug; 13(4):307-13. PubMed ID: 20443718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of vascular reactivity in pregnancy: the basis for therapeutic approaches to prevent pregnancy-induced hypertension.
    Magness RR; Gant NF
    Semin Perinatol; 1994 Apr; 18(2):45-69. PubMed ID: 8066476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of certain humoral factors in the pathogenesis of hypertension in pregnancy].
    Shekhtman MM; Afonina LI; Smirnova GA; Vinogradova LA; Egorova IA
    Akush Ginekol (Mosk); 1976 Jan; (1):48-51. PubMed ID: 970561
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension. Mutation points to salt recycling pathway.
    Wickelgren I
    Science; 2000 Jul; 289(5476):23-6. PubMed ID: 10928921
    [No Abstract]   [Full Text] [Related]  

  • 9. The molecular basis of hypertension.
    Toka HR
    Turk J Pediatr; 2002; 44(3):183-93. PubMed ID: 12405428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperaldosteronism in pregnancy.
    Escher G
    Ther Adv Cardiovasc Dis; 2009 Apr; 3(2):123-32. PubMed ID: 19171690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma progesterone and aldosterone in pregnancy.
    Ledoux F; Genest J; Nowaczynski W; Kuchel O; Lebel M
    Can Med Assoc J; 1975 Apr; 112(8):943-7. PubMed ID: 1131766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension and pregnancy.
    Peart WS
    Trans Med Soc Lond; 1965; 81():110-2. PubMed ID: 5889783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possible correlations between the electrolyte picture and plasma levels of aldosterone in pregnancy complicated by hypertension].
    Mazzanti L; Bertoli E; Testa I; Rabini RA; Tranquilli AL; Romanini C; Signore R; Tocchini M; Sprovieri G
    Recenti Prog Med; 1987 Apr; 78(4):157-9. PubMed ID: 2957762
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical clarification of the effects of rutin derivatives].
    Kappert A
    Angiologica; 1972; 9(3-6):401-7. PubMed ID: 4669477
    [No Abstract]   [Full Text] [Related]  

  • 16. Mineralocorticoids in normal and hypertensive pregnancies.
    Ehrlich EN
    Semin Perinatol; 1978 Jan; 2(1):61-71. PubMed ID: 216116
    [No Abstract]   [Full Text] [Related]  

  • 17. Mineralocorticoid resistance.
    Geller DS
    Clin Endocrinol (Oxf); 2005 May; 62(5):513-20. PubMed ID: 15853818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Density of alpha1-and alpha 2-adrenergic receptors in platelets, activity of plasma renin and level of noradrenaline, adrenaline and aldosterone in serum of women with uncomplicated pregnancy and women with hypertension during pregnancy].
    Halawa B; Robaczyński J
    Pol Tyg Lek; 1991 Apr 22-29; 46(17-18):317-9. PubMed ID: 1669062
    [No Abstract]   [Full Text] [Related]  

  • 19. [The level of plasma renin and plasma aldosterone activity in normotensive women and in pregnancy-induced arterial hypertension in a group of women from Cameroon].
    Youmbissi TJ; Tedong F; Tapster S; Nash BT
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(6):802-4. PubMed ID: 1822488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of pregnancy plasma angiotensin II and aldosterone level in hypertensive states].
    Zheng XX
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):36-7, 62. PubMed ID: 3595306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.